As of Apr 24
| -0.16 / -3.38%|
The 7 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +74.67% increase from the last price of 4.58.
The current consensus among 7 polled investment analysts is to Hold stock in AcelRx Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.